You might think you’re making new medicines, but if you’re a biotech startup, your primary deliverable over the next 5–10 years will be data.
At every critical stage — from the weekly research meeting, to the CEO presenting to her board of directors, to the first IND submitted to the FDA, to the IPO filing with the SEC — the outcome depends on successful delivery of a data package. So why is the choice of software tools for managing and communicating that data — such an essential part of your company’s operations — often left as an afterthought relegated to the IT department?